Izinsizakalo Zokulungisa Okubikezelayo Zithembele ku-CT, i-MRI, kanye ne-Ultrasound njengezindlela ezihamba phambili.

Ngokusho kombiko we-IMV 2023 Diagnostic Imaging Equipment Service Outlook okhishwe muva nje, isilinganiso esimaphakathi sokubaluleka kokusebenzisa noma ukwandisa izinhlelo zokulungisa ezibikezelayo zesevisi yemishini yokuthwebula izithombe ngo-2023 singu-4.9 kwabangu-7.

Ngokuphathelene nosayizi wesibhedlela, izibhedlela ezinemibhede engu-300 kuya ku-399 zithole isilinganiso esiphezulu kakhulu esingu-5.5 kwezingu-7, kanti izibhedlela ezinemibhede engaphansi kwe-100 zinesilinganiso esiphansi kakhulu esingu-4.4 kwezingu-7. Ngokuphathelene nendawo, izindawo zasemadolobheni zithole isilinganiso esiphezulu esingu-5.3 kwezingu-7, kanti izindawo zasemaphandleni zinesilinganiso esiphansi kakhulu esingu-4.3 kwezingu-7. Lokhu kusikisela ukuthi izibhedlela ezinkulu nezikhungo ezindaweni zasemadolobheni kungenzeka kakhulu ukuthi zibeke phambili ukusetshenziswa kwezici zesevisi yokulungisa okubikezelayo emishinini yazo yokuthwebula izithombe.

Izindlela ezihamba phambili zokuthatha izithombe lapho izici zokulungisa izibikezelo zibhekwa njengezibaluleke kakhulu yi-CT, njengoba kuboniswe yi-83% yabaphenduli, i-MRI ku-72%, kanye ne-ultrasound ku-44%. Abaphenduli bagcizelele ukuthi inzuzo eyinhloko yokusebenzisa ukulungiswa kwezibikezelo ekuhlinzekeni imishini yokudweba izithombe ukuthuthukisa ukuthembeka kwemishini, okucashunwe yi-64% yabaphenduli. Ngakolunye uhlangothi, ukukhathazeka okukhulu okuhlobene nokusebenzisa ukulungiswa kwezibikezelo ukwesaba izinqubo nezindleko zokulungisa ezingadingekile, okucashunwe yi-42% yabaphenduli, kanye nokungaqiniseki ngomthelela wako kumamethrikhi okusebenza abalulekile, njengoba kushiwo yi-38% yabaphenduli.

Ngokuphathelene nezindlela ezahlukene zokunikeza izinsizakalo zokuxilonga izithombe zemishini yokuthwebula izithombe, indlela eyinhloko ukulungiswa kokuvimbela, okusetshenziswa yi-92% yezindawo, kulandelwe ukulungiswa kwe-reactive (break fix) ku-60%, ukulungiswa kokubikezela ku-26%, kanye nokusekelwe emiphumeleni ku-20%.

Ngokuphathelene nezinsizakalo zokulungisa izibikezelo, ama-38% abahlanganyeli benhlolovo bathi ukuhlanganisa noma ukwandisa uhlelo lwezinsizakalo zokulungisa izibikezelo kuyinto eza kuqala (elinganiswe ngo-6 noma 7 kwabayi-7) enkampanini yabo. Lokhu kuhlukile ku-10% wabaphenduli abakubheka njengento eza kuqala (elinganiswe ngo-1 noma 2 kwabayi-7), okuholele esilinganisweni esihle sama-28%.

Umbiko Wesevisi Ye-IMV Wokubuka Imishini Yokuthwebula Izithombe ka-2023 uhlola izitayela zemakethe ezizungeze izinkontileka zesevisi zemishini yokuthwebula izithombe ezibhedlela zase-US. Umbiko owashicilelwa ngo-Agasti 2023, usekelwe empendulweni evela kubaphathi nabaphathi be-radiology kanye ne-biomedical abangu-292 abahlanganyele ocwaningweni lukazwelonke lwe-IMV kusukela ngoMeyi 2023 kuya kuJuni 2023. Lo mbiko uhlanganisa abathengisi abanjengo-Agfa, Aramark, BC technical, Canon, Carestream, Crothall Healthcare, Fujifilm, GE, Hologic, Konico Minolta, Philips, Renovo Solutions, Samsung, Shimadzu, Siemens, Sodexo, TriMedx, Unisyn, United Imaging, Ziehm.

Ukuze uthole ulwazi mayelanaumshini wokujova wemidiya ehlukene (i-injector yemidiya yokungafani ecindezeleke kakhulu), sicela uvakashele iwebhusayithi yethu yenkampani ku-https://www.lnk-med.com/noma uthumele i-imeyili ku-info@lnk-med.comukukhuluma nommeleli. I-LnkMed iwumkhiqizo wobungcweti kanye nokuthengisa kwe-uhlelo lokujova i-ejenti yokuqhathanisaifektri, imikhiqizo ithengiswa ekhaya nakwamanye amazwe, isiqinisekiso sekhwalithi, iziqu eziphelele. Sicela usithinte uma unemibuzo.